HEINEKEN NV : Global Fund and HEINEKEN Enter Into Partnership to Fight Against Infectious Diseases in Africa

Davos, 26 January 2018 - The Global Fund and HEINEKEN today launched a new partnership, joining forces to further advance a common goal: ending HIV, tuberculosis and malaria as epidemics in Africa.

As part of the partnership, HEINEKEN will lend its expertise in the areas of logistics and communications to support the Global Fund in better reaching specific demographic groups that are most at risk of HIV, tuberculosis and malaria.

At the core of the partnership, HEINEKEN will pair supply chain experts with logistics planners at the Global Fund to share expertise in demand-forecasting and quality control during shipment. Locally, HEINEKEN will support efforts in countries in Africa where the company is present to improve the effectiveness of the "last mile" distribution, which focuses on ensuring the proper materials can reach health care facilities and patients in remote areas. This is presently already taking place in DRC, South Africa and Nigeria.

Through a series of workshops and creative support, HEINEKEN marketers will also provide communications services to the Global Fund to ensure they are reaching the right audience, with the right message at the right time. 

"The Global Fund is a strong believer in the power of public-private partnerships in order to accelerate progress," said Peter Sands, incoming Executive Director of the Global Fund. "We are particularly excited to leverage the expertise of HEINEKEN as we develop innovative tools and approaches that will promote HIV prevention and behaviour change. We also look forward to sharpening our logistics planning skills to better support our implementing partners' efforts to deliver health services and commodities wherever they are needed. These two efforts are vital to improving health and well-being in Africa."

"HEINEKEN has been present in Africa for over 100 years, and saw first-hand the severity of the AIDS epidemic on communities. We provided employees with voluntary testing for HIV and treatment for HIV, tuberculosis and malaria among others from the start," said Jean-François van Boxmeer, CEO and Chairman of the Executive Board of HEINEKEN. "We continue to do this today and recognize there is still a lot to do. Evolving our partnership with the Global Fund will allow us to work together in order to end these epidemics in Africa. We greatly respect the work the Global Fund supports, and we look forward to extending our partnership."

HEINEKEN is currently a member of the Private Sector Delegation to the Board of the Global Fund. HEINEKEN medical doctors have been involved in the Country Coordinating Mechanisms that direct the Global Fund financing of country programs in DRC and Burundi. The new partnership will expand the geographical scope of activities.

- ENDS -

Editorial information:

For more information, please contact:

Dayna Adelman - Dayna.Adelman@heineken.com 

Gretchen Lyons - Gretchen.Lyons@theglobalfund.org

About HEINEKEN:

HEINEKEN is the world's most international brewer. It is the leading developer and marketer of premium beer and cider brands. Led by the Heineken® brand, the Group has a portfolio of more than 250 international, regional, local and speciality beers and ciders. We are committed to innovation, long-term brand investment, disciplined sales execution and focused cost management. Through "Brewing a Better World", sustainability is embedded in the business and delivers value for all stakeholders. HEINEKEN has a well-balanced geographic footprint with leadership positions in both developed and developing markets. We employ over 80,000 employees and operate breweries, malteries, cider plants and other production facilities in more than 70 countries. Heineken N.V. and Heineken Holding N.V. shares trade on the Euronext in Amsterdam. Prices for the ordinary shares may be accessed on Bloomberg under the symbols HEIA NA and HEIO NA and on Reuters under HEIN.AS and HEIO.AS. HEINEKEN has two sponsored level 1 American Depositary Receipt (ADR) programmes: Heineken N.V. (OTCQX: HEINY) and Heineken Holding N.V. (OTCQX: HKHHY). Most recent information is available on HEINEKEN's website: www.theHEINEKENcompany.com and follow us on Twitter via @HEINEKENCorp.

             

About the Global Fund to Fight AIDS, Tuberculosis and Malaria:

The Global Fund is a 21st-century partnership designed to accelerate the end of AIDS, tuberculosis and malaria as epidemics. As a partnership between governments, civil society, the private sector and people affected by the diseases, the Global Fund mobilizes and invests nearly US$4 billion a year to support programs run by local experts in more than 100 countries. By challenging barriers and embracing innovative approaches, we are working together to better serve people affected by the diseases.